BridgeMD
New treatment option for Osgood-Schlatter Disease
Official title Low-Level Laser Therapy for Osgood-Schlatter or Sever Pain in Youth Athletes
ClinicalTrials.gov ID: NCT07446517
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if low-level laser therapy (also called photobiomodulation) works to treat knee or heel pain in physically active children and adolescents with Osgood-Schlatter disease or Sever disease. It will also learn about the safety of this treatment.
- Time commitment: about 2 weeks
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 10 to 17
You may be able to join if
- Aged 10 to 17 years
- Participates in organized sport with at least 12 months of training history
- Has knee pain at the tibial tubercle (Osgood-Schlatter-type pain) and/or heel pain at the back of the heel (Sever-type pain)
- Pain is worse with activity and reproduced by pressing on the painful area
- Pain intensity is 3 out of 10 or higher on the Numeric Pain Rating Scale (NPRS) during the clinical visit and in the last week (0 = no pain, 10 =...
You likely can't join if
- Current pain episode started after an acute injury (for example, fall, collision, ankle sprain, or similar trauma)
- Prior surgery on the lower limb
- Known diagnosis of patellofemoral pain syndrome (pain around/behind the kneecap)
- Known patellar instability (recurrent kneecap dislocations or giving way)
- Known complex regional pain syndrome
- History of lower-limb fracture
See the full eligibility criteria
- Aged 10 to 17 years
- Participates in organized sport with at least 12 months of training history
- Has knee pain at the tibial tubercle (Osgood-Schlatter-type pain) and/or heel pain at the back of the heel (Sever-type pain)
- Pain is worse with activity and reproduced by pressing on the painful area
- Pain intensity is 3 out of 10 or higher on the Numeric Pain Rating Scale (NPRS) during the clinical visit and in the last week (0 = no pain, 10 = worst pain imaginable)
- Symptoms have been present for at least 2 weeks
- For heel pain consistent with Sever disease, the heel squeeze test is positive
- Ultrasound shows findings consistent with an apophyseal injury at the painful site
- Has no signs of acute illness or infection on the assessment day and during the previous 14 days (for example, fever or "flu-like" symptoms)
- A parent/guardian provides written informed consent
- The participant provides assent (agreement) to take part
- Current pain episode started after an acute injury (for example, fall, collision, ankle sprain, or similar trauma)
- Prior surgery on the lower limb
- Known diagnosis of patellofemoral pain syndrome (pain around/behind the kneecap)
- Known patellar instability (recurrent kneecap dislocations or giving way)
- Known complex regional pain syndrome
- History of lower-limb fracture
- Ultrasound shows clinically important abnormalities in the assessed area that are not consistent with the target condition (for example, calcifications or other significant findings)
- Known chronic or systemic disease that may affect the musculoskeletal system (for example, inflammatory joint disease or other clinically significant chronic conditions)
- Received any of the following in the last 3 months: steroid injection, hydrodilatation, or laser therapy
- Used non-steroidal anti-inflammatory drugs (NSAIDs) (for example, ibuprofen, naproxen) within the last 14 days, or currently uses them
- Clinically important abnormal blood test results (complete blood count) that may affect safety or data validity
- Parent/guardian or participant does not agree to participate, or withdraws consent/assent
The study team makes the final eligibility decision.
Where it's taking place
- Gdansk, Pomeranian, Poland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 2 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 10 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Gdansk, Pomeranian, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.